AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)
$14.88 -0.12 (-0.8%)
Analysed AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) News Sources
Aurinia Pharmaceuticals' (AUPH) CEO Bought 815,000 Shares for $12.5 Million
07-06-2026
fool.com
A Fresh Look At Aurinia Pharmaceuticals (AUPH) Valuation After Recent Share Price Consolidation
11-06-2026
yahoo.com
Aurinia Pharmaceuticals and Four More Stocks See Activist Action
12-06-2026
yahoo.com
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
23-06-2026
yahoo.com
5 Small Drug Stocks to Invest in Amid a Biotech Comeback
25-06-2026
yahoo.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
26-06-2026
yahoo.com
Is Aurinia Pharmaceuticals Inc. (AUPH) A Good Stock To Buy Now?
29-06-2026
yahoo.com
Aurinia (AUPH) Upgraded to Strong Buy: Here's Why
02-07-2026
yahoo.com
Aurinia Announces Initiation of PRESERVE, a Study Investigating the Combination of LUPKYNIS and Belimumab, Obinutuzumab or Anifrolumab in Patients with Lupus Nephritis
06-07-2026
yahoo.com
Karyopharm Therapeutics (KPTI) Soars 5.3%: Is Further Upside Left in the Stock?
22-07-2026
yahoo.com
What is the current price of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The current price of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is $14.88.
AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) absolute price change since previous trading day?
The absolute price change of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) since the previous trading day is $-0.12.
AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) percentage price change since previous trading day?
The percentage price change of AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) since the previous trading day is -0.8%.
What is the most recent average sentiment score for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The most recent average sentiment score for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)?
The most recent sentiment for AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ) is .
SEC-8K** Filing Available For AURINIA PHARMACEUTICALS INC (AUPH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.